Current Status of Talcum Powder Claims
Talcum powder claims continue to dominate mass tort litigation in the United States, with thousands of plaintiffs alleging that long-term use of talc-based products caused ovarian cancer or mesothelioma. Johnson & Johnson remains the primary defendant, facing over 40,000 pending lawsuits as of mid-2025, and the company has recorded billions in reserves to cover potential losses according to Forbes. Other manufacturers, including Imerys Talc America and Tyco International, have also faced claims, with some reaching early settlement agreements while others proceed to trial.
The legal strategy in talcum powder claims centers on proving that manufacturers knew about asbestos contamination risks yet failed to warn consumers. Internal documents revealed during discovery have shown that some companies were aware of asbestos traces in their raw talc as early as the 1970s per SEC filings. Recent judicial rulings have allowed a mix of personal injury and wrongful death claims to move forward, keeping the docket full across federal and state courts.
Health Risks and Scientific Evidence
The primary health risk cited in talcum powder claims is the development of ovarian cancer when talc particles are applied to the genital area. The International Agency for Research on Cancer classifies talc containing asbestos as carcinogenic to humans, and even asbestos-free talc is listed as possibly carcinogenic per IARC classifications. Studies published in major medical journals have shown a modest but statistically significant increase in ovarian cancer risk among women who regularly use talcum powder in the perineal area.
Mesothelioma claims, though less common, arise from inhaling talc fibers that contain trace amounts of asbestos. This cancer affects the lining of the lungs and abdomen, with a latency period often spanning several decades. Pathologists and oncologists serving as expert witnesses in talcum powder claims rely on biopsy results and exposure histories to establish a causal link between talc use and the diagnosis according to the American Cancer Society.
Major Settlements and Financial Impact
Johnson & Johnson Bankruptcy and Reorganization
Johnson & Johnson filed for Chapter 11 bankruptcy in 2023 to manage talcum powder claims through a reorganization plan that created the LTL Management LLC trust. The trust was funded with $2 billion initially, with additional payments tied to future claim payouts, aiming to resolve the litigation in a structured way as reported by Forbes. This move delayed thousands of trials but also drew criticism from plaintiffs who argue the company is using bankruptcy to shield its parent assets.
Recent Verdicts and Payouts
In 2024 and 2025, several talcum powder claim verdicts resulted in payouts ranging from tens of millions to over $2 billion in a single case, though many of these amounts were reduced or overturned on appeal. The variability in outcomes reflects differences in jurisdiction, evidence quality, and the specific talc product at issue. Companies involved